Search Results - "Serra, M.A."

Minimal hepatic encephalopathy is associated with increased capacity to eliminate superoxide and peroxynitrite in lymphocytes by Mangas-Losada, A, Garcia-Garcia, R, Izquierdo-Altarejos, P, Gimenez-Garzó, C, Urios, A, Escudero-García, D, Tosca, J, González-López, O, Giner-Durán, R, Serra, M.A, Felipo, V, Montoliu, C

Get full text

Prevalence of hepatitis C in the spanish population. The prevhep study (ethon cohort) by Lavin, A.C, Perello, C, Llerena, S, Gomez, M, Escudero, M.D, Rodriguez, L, Estebanez, A, Gamez, B, Puchades, L, Cabezas, J, Serra, M.A, Calleja, J.L, Crespo, J

Get full text

Effectiveness of ribavirin use associated with direct-acting antivirals in the treatment of non-cirrhotic patients with genotype 1a or 4 HCV infection in real-world practice by Ruiz-Antorán, B, Rincón, D, Conde, M.H, Fernández, I, García-Samaniego, J, Gea, F, Cabezas, J, Sacristán, B, Jorquera, F, Turnes, J, Prieto, M, Llaneras, J, Pascasio, J.M, Royuela, F.S, Lens, S, Serra, M.A, Morillas, R.M, Torras, X, Andrade, R.J, Bermejo, M.F, Ampuero, J, Molina, E, Bonet, L, Diago, M, Salcines, J.R, Moreno, J.M, Crespo, J, Panero, J.L.C

Get full text

Adherence to SmPC recommendations in real-world practice in the treatment of monoinfected patients with chronic genotype 1 or 4 HCV infection with direct-acting antivirals by Ruiz-Antorán, B, Rincón, D, Perelló, C, Fernandez, I, Gea, F, Mariño, Z, García-Samaniego, J, Hontangas, V, Cabezas, J, Sacristan, B, Pascasio, J.M, Morillas, R.M, Turnes, J, Llaneras, J, Serra, M.A, Torras, X, Diago, M, Jorquera, F, Fernández, C, Simón, M.A, Bermejo, M.F, Ruano, J.J.S, Arenas, J, Andrade, R.J, Ampuero, J, Bonet, L, Crespo, J, Panero, J.L.C

Get full text

Effectiveness, safety/tolerability of OBV/PTV/r ± DSV in patients with HCV genotype 1 or 4 with/without HIV-1 co-infection, chronic kidney disease (CKD) stage IIIb/V and dialysis in Spanish clinical practice – preliminary data Vie-KinD study by Londoño, M.-C, Garcia-Buey, L, Mallolas, J, Barril, G, Ahumada, A, Riveiro-Barciela, M, Muñoz-Gomez, R, Roget, M, Serra, M.A, Devesa, M.J, Navascues, C, Baliellas, C, Aldamiz-Echevarria, T, Gutierrez, M.L, Carmona, I, Polo-Lorduy, B, Bonet, L, Garcia-Samaniego, J, Jiménez, M, Prieto, M, Moran, S, Castro, A, Delgado, M, Gea, F, Martin-Granizo, I, Montes, M, Morano, L, Castaño, M.A, De los Santos, I, Laguno, M, Losa, J.E, Montero, M, Rivero, A, Manzanares, A, De Alvaro, C

Get full text

P0159 : Non invasive blood flow measurement by “arterial spin labeling” detects minimal hepatic encephalopathy by Urios, A, Gímenez-Gascó, C, Agustí, A, Mangas-Losadas, A, Garcia, R, Escudero-Sanchis, A, Escudero-García, D, González, O, Serra, M.A, Giner-Durán, R, Belloch, V, Felipo, V, Montoliu, C

Get full text

800 UTILITY OF ITPA GENOTYPING TO PREDICT EARLY SEVERE ANEMIA IN CHRONIC HEPATITIS C PATIENTS RECEIVING TRIPLE THERAPY by Camós, S, Buti, M, Serra, M.A, Rodríguez-Frías, F, Escudero, A, Homs, M, Rodríguez, F, Tabernero, D, Esteban, R

Get full text

P1183 VIRAL BREAKTHROUGH DURING TRIPLE THERAPY: CAUSES OF NON RESPONSE IN A MULTICENTRIC COHORT by Calleja Panero, J.L, Crespo, J, Rodríguez, R, Serra, M.A, Pascasio, J.M, Sola, R, Morillas, R, Romero, M, Lens, S, García Samaniego, J, Ruiz Antorán, B, Turnes, J

Get full text

Effectiveness and Safety of Ombitasvir, Paritaprevir, Ritonavir and Dasabuvir Patients with Genotype 1 Chronic Hepatitis C Virus Infection: Results from the Spanish Real World Cohort by Calleja, J.L, Rincon, D, Ruiz-Antoran, B, Sacristan, B, Perello, C, Lens, S, Fernanadez, I, Gea, F, Morillas, R.M, Cabezas, J, Pascasio, J.M, Prieto, M, Turnes, J, Serra, M.A, Arenas, J, Torras, X, Bonet, L, Fernandez, C, Samaniego, J, Hernandez-Albujar, A, Ampuero, J, Moreno, J.M, Saez-Royuela, F, Alvarez-Navascues, C, Diago, M, Sanchez-Antolin, G, de la Vega, J, Sanchez-Ruano, J.J, Andrade, R, Butti, M, Carrion, J.A, Molina, E, Simon, M.A, Salcines, J.R, Jorquera, F, Montoliu, S, Ahumada, A, Hernaez, T, Crespo, J

Get full text

Effectiveness and Safety of Sofosbuvir/Ledipasvir Treatment for Monoinfected Genotype 1 HCV Patients in Real-Life Clinical Practice: Results from Spanish Hepa-C Cohort by Crespo, J, Fenandez, I, Cabezas, J, Albillos, A, Perello, C, Garcia-Samaniego, J, Serra, M.A, Diago, M, Pascasio, J.M, Prieto, M, Llerena, S, Mariño, Z, Fernandez, C, Buti, M, Bañares, R, Simon, M.A, Turnes, J, Sacristan, B, Jorquera, F, Lopez, C, Salcines, J.R, Ampuero, J, Sanchez-Ruano, J.J, Morillas, R, Navascues, C.A, de la Vega, J, Bonet, L, Cuaresma, M, Andrade, R, Carrion, J.A, Royuela, F.S, Iacono, O.L, Sanchez-Antolin, G, Molina, E, Ruiz, J.A, Montoliu, S, Torras, X, Moreno, J.M, Pobre, P.S, Fernandez, J.R, Bermejo, M.F, Gea, F, Romero, M, Garcia, D.E, Manzano, M.L, Calleja, J.L

Get full text

589 PATIENTS WITH MINIMAL HEPATIC ENCEPHALOPATHY SHOW IMPAIRED MISMATCH NEGATIVITY CORRELATING WITH REDUCED PERFORMANCE IN ATTENTION TESTS by Felipo, V, Ordoño, J.F, Urios, A, Gimenez-Garzo, C, Gonzalez, O, Giner, R, Serra, M.A, Wassel, A, Rodrigo, J.M, Salazar, J, Montoliu, C

Get full text

638 3-NITRO-TYROSINE AS A PERIPHERAL BIOMARKER OF MINIMAL HEPATIC ENCEPHALOPATHY IN PATIENTS WITH LIVER CIRRHOSIS by González-López, O, Urios, A, Cauli, O, Piedrafita, B, Ordoño, F, Gimenez-Garzó, C, El Mlili, N, Giner-Duran, R, Serra, M.A, Salazar, J, Carda, C, Belloch, V, Felipo, V, Montoliu, C

Get full text

94A Implementing a New Nursing Model at Organisational Level in a Cancer Centre – “Nurse Accompanies” by Toro, D, Corrales, E, Delgado, J.E, Duran, A, Serra, M.A

Get full text

P.2.b.018 Genes differentially expressed in CB1 knockout mice: involvement in the depressive-like phenotype by Aso, E, Ozaita, A, Busquets, A, Serra, M.A, Maldonado, R

Get full text

526 HYPERAMMONEMIA AND INFLAMMATION IN THE INDUCTION OF MINIMAL HEPATIC ENCEPHALOPHATY by Urios, A, Gimenez, C, Wassel, A, Gonzalez, O, Serra, M.A, Giner, R, del Olmo, J.A, Rodrigo, J.M, Felipo, V, Montoliu, C

Get full text

786 PEGINTERFERON PLUS RIBAVIRIN AND SUSTAINED VIROLOGICAL RESPONSE ON HCV CIRRHOSIS: EFFECT ON LIVER-RELATED EVENT FREE SURVIVAL AND FACTORS PREDICTING RESPONSE: A RETROSPECTIVE MULTICENTER ANALYSIS by Fernandez Rodriguez, C.M, Alonso, S, Gutierrez, M.L, Temino, R, Barcena, R, Serra, M.A, Rodriguez, F, Erdozain, J.C, Carrion, G, Fernandez, I, Castellanos, G, Romero-Gomez, M, Madrazo, A, de Cuenca, B, Gomez-Rubio, M, Fuentes, J, Sola, R, Aviles, J.F

Get full text

P0169 : Critical flicker frequency predicts survival in patients with liver cirrhosis by Ampuero, J, Simón, M, Montoliú, C, Jover, R, Serra, M.Á, Córdoba, J, Romero-Gómez, M

Get full text

Crítica de libros y medios audiovisuales by Serra-Segarra, M.A

Get full text

P1178 TELAPREVIR-BASED TRIPLE THERAPY IN PATIENTS WITH MODERATE FIBROSIS. SPANISH MULTICENTRE STUDY IN CLINICAL PRACTICE by Cabezas Gonzalez, J, Diago, M, Berenguer, M, Broquetas, T, Serra, M.Á, Morillas, R, García-Samaniego, J, Calleja, J.L, Sánchez, J.J, Lens, S, Soto-Fernández, S, Sacristan, B, Fernández, I, López-Nuñez, C, Buti, M, Romero-Gómez, M, Sáez-Royuela, F, Fernández, C, Jorquera, F, Sánchez-Antolín, G, Pascasio, J.M, Cuadrado, A, Hernández-Guerra, M, Crespo, J

Get full text

THU-190 - Prevalence of hepatitis C in the spanish population. The prevhep study (ethon cohort) by Lavin, A.C., Perello, C., Llerena, S., Gomez, M., Escudero, M.D., Rodriguez, L., Estebanez, A., Gamez, B., Puchades, L., Cabezas, J., Serra, M.A., Calleja, J.L., Crespo, J.

Get full text